SEMMs: Somatically Engineered Mouse Models – A New Tool for Translational Preclinical Research
Time: 10:30 am
day: Day One
Details:
- Animal models of cancer are key to understand the mechanism of action of drugs and their influence on the tumour microenvironment
- SEMMs with the CRISPR/Cas9 system have optimised and made more agile mouse modelling
- SEMMs can be integrated in the drug discovery pipeline at different levels
